Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
Cancers (Basel). 2023 Apr 1;15(7):2117. doi: 10.3390/cancers15072117.
Cancers (Basel). 2023.
PMID: 37046778
Free PMC article.
Clinical characteristics of critically ill patients with COVID-19.
Carboni Bisso I, Huespe I, Lockhart C, Massó A, Gonzalez Anaya J, Hornos M, Famiglietti R, Di Grazia M, Coria P, San Román E, Las Heras M.
Carboni Bisso I, et al.
Medicina (B Aires). 2021;81(4):527-535.
Medicina (B Aires). 2021.
PMID: 34453793
Free article.
English.
Item in Clipboard
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials.
Martini G, Ciardiello D, Famiglietti V, Rossini D, Antoniotti C, Troiani T, Napolitano S, Esposito L, Latiano TP, Maiello E, Del Re M, Lonardi S, Aprile G, Santini D, Masi G, Avallone A, Normanno N, Pietrantonio F, Pinto C, Ciardiello F, Cremolini C, Martinelli E.
Martini G, et al.
Cancer Med. 2023 Apr;12(8):9392-9400. doi: 10.1002/cam4.5699. Epub 2023 Mar 7.
Cancer Med. 2023.
PMID: 36880426
Free PMC article.
Item in Clipboard
Synthetic Versus Biological Mesh in Laparoscopic and Open Ventral Hernia Repair (LAPSIS): Results of a Multinational, Randomized, Controlled, and Double-blind Trial.
Miserez M, Lefering R, Famiglietti F, Mathes T, Seidel D, Sauerland S, Korolija D, Heiss M, Weber G, Agresta F, Steup WH, Śmietański M, Ribeiro R, Cuccurullo D, Catena F, Rudroff C, Rosanelli G, Schön F, Smet B, Wenger F, Saad S, Naver L, Neugebauer E.
Miserez M, et al.
Ann Surg. 2021 Jan 1;273(1):57-65. doi: 10.1097/SLA.0000000000004062.
Ann Surg. 2021.
PMID: 33332873
Clinical Trial.
Item in Clipboard
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs.
Orditura M, Della Corte CM, Diana A, Ciaramella V, Franzese E, Famiglietti V, Panarese I, Franco R, Grimaldi A, Lombardi A, Caraglia M, Santoriello A, Procaccini E, Lieto E, Maiello E, De Vita F, Ciardiello F, Morgillo F.
Orditura M, et al.
Breast. 2018 Oct;41:165-171. doi: 10.1016/j.breast.2018.08.002. Epub 2018 Aug 4.
Breast. 2018.
PMID: 30103105
Item in Clipboard
Cite
Cite